Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01495923 · ClinicalTrials.gov registry record · NA
Steroids Versus Gabapentin
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT01495923: Completed NA study, sponsored by Johns Hopkins University.
NCT01495923 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 145 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01495923, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pharmacotherapy or epidural steroid injections are a better treatment for lumbosacral radicular pain. 142 patients referred to a participating pain clinic with lumbosacral radiculopathy will be randomized in a 1:1 ratio to receive one of two treatments. Half (n=71) of the patients will be allocated to receive an epidural steroid injection (ESI; group I), with an equal number allocated to receive gabapentin (group II). Patients \& evaluating physicians will be blinded. Follow-up will be through 3-months after treatment.
Interventions
- DRUG Gabapentin
- PROCEDURE epidural steroid injection
- PROCEDURE Sham epidural steroid injection
- DRUG Placebo gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01495923
The ClinicalTrials.gov registry entry for NCT01495923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Gabapentin is the first listed.
NCT01495923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01495923 about?
NCT01495923 is a clinical study titled "Steroids Versus Gabapentin". The purpose of this study is to determine whether pharmacotherapy or epidural steroid injections are a better treatment for lumbosacral radicular pain. 142 patients referred to a participating pain clinic with lumbosacral radiculopathy will be randomized in a 1:1 ratio to receive one of two treatme...
What is the current status of trial NCT01495923?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2011-12. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01495923?
The interventions under investigation include: Gabapentin (DRUG), epidural steroid injection (PROCEDURE), Sham epidural steroid injection (PROCEDURE), Placebo gabapentin (DRUG).
Who is sponsoring clinical trial NCT01495923?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.